Dr Shantanu Sengupta
Dr Nduka Okwose
Dr Guy MacGowan
Professor Djordje Jakovljevic
| Cardiac response to pharmacological stress in heart failure reduced and heart failure preserved ejection fraction | 2024 |
|
Dr Sarah Charman
Dr Alasdair Blain
Dr Nduka Okwose
Amy Fuller
Alaa Alyahya
et al. | Physical Activity, Inactivity and Sleep in Individuals with Hypertrophic Cardiomyopathy | 2024 |
|
Dr Nduka Okwose
Dr Sarah Charman
Professor Djordje Jakovljevic
| The ventilatory efficiency parameters outperform peak oxygen consumption in monitoring the therapy effects in patients with hypertrophic cardiomyopathy | 2024 |
|
Dr Nduka Okwose
Amy Fuller
Alaa Alyahya
Dr Sarah Charman
Dr Christopher Eggett
et al. | Application of non-invasive bioreactance to assess hemodynamic function in patients with hypertrophic cardiomyopathy | 2023 |
|
Alaa Alyahya
Dr Sarah Charman
Dr Nduka Okwose
Amy Fuller
Professor Christopher Eggett
et al. | Heart rate variability and haemodynamic function in individuals with hypertrophic cardiomyopathy | 2023 |
|
Dr Nduka Okwose
Dr Guy MacGowan
Professor Djordje Jakovljevic
| Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy | 2023 |
|
Dr Sarah Charman
Dr Nduka Okwose
Dr Guy MacGowan
Professor Djordje Jakovljevic
| Insights into heart failure hospitalizations, management, and services during and beyond COVID-19 | 2021 |
|
Professor Djordje Jakovljevic
Dr Nduka Okwose
Dr Paul Brennan
Dr Guy MacGowan
| Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy | 2020 |
|
